Angela graduated Phi Beta Kappa from Yale University in 2012 with a B.S. in Intensive Chemistry. She recently completed her Ph.D. in Chemical Biology at Harvard University, with a focus on small molecule probe and drug development towards neurodegenerative diseases. She was a National Science Foundation Fellow and is a Board Member of Harvard's Science in the News, an organization that seeks to make science accessible to the public. She worked as an entrepreneurial fellow at Flagship Pioneering in Cambridge, a life-science venture capital firm, and she currently a Consultant of Platform Strategy at Kintai Therapeutics.
High school: North Hollywood High School
Yale CollegeNew Haven, CT
|2012||B.S. Intensive Chemistry|
Harvard UniversityCambridge, MA
|2017||Ph.D. Chemical Biology|